Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of parkinsons disease
Potential Research Applications: Antimicrobial and infection control models Wound healing and skin regeneration studies Immune system modulation and inflammation research Studies on epithelial repair and barrier function For laboratory research use only
Eng licensed the discovery to an outside pharmaceutical company so it could be developed into a drug
Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, et al
One-time price $199 | In stock ready to ship It takes just a few minutes to complete some questions about your medical history
The common therapeutic approach for these disorders is aimed at regulating circulating GH and IGF-1 levels using recombinant hormone therapy,8 but ongoing in vitro and in vivo studies are employing newer methods of treatment